Biden Policy Will Make 10 Popular Medicines Less Expensive For Those With Medicare, 38% -79% [View all]

Biden policy will make 10 popular medicines less expensive for those with Medicare, The Guardian, Aug. 13, 2024. Ed. 💊
- First of its kind US policy will mean discounts on 2023 prices ranging from 38% to 79%.
------
Joe Biden's administration announced a landmark healthcare negotiation on Thursday in which 10 popular medications will now be available at lower prices for Medicare beneficiaries. The discounts on the 2023 prices ranged from 38% to 79%, according to the figures released by the Centers for Medicare & Medicaid (CMS). The 10 drugs are:

Januvia (diabetes), Fiasp (diabetes), Farxiga (diabetes, heart failure, kidney disease), Enbrel (arthritis and psoriasis), Jardiance (diabetes, heart and kidney disease), Stelara (arthritis, psoriasis and colitis), Xarelto (blood clots), Eliquis (blood clots), Entresto (heart failure) and Imbruvica (blood cancers).

The new policy, which is the first of its kind in the US, was part of the Inflation Reduction Act, which Democrats passed in 2022. It gives people on Medicare, a government insurance plan for seniors above 65, financial relief amid increasing health costs.

“For years, millions of Americans were forced to choose between paying for medications or putting food on the table, while Big Pharma blocked Medicare from being able to negotiate prices on behalf of seniors and people with disabilities,” Biden said in a statement. “But we fought back – and won.” Biden’s statement also pointed out that no Republicans voted for the bill, which also includes climate legislation...

https://www.theguardian.com/us-news/article/2024/aug/15/biden-policy-medicines-less-expensive